Unicycive Therapeutics (Nasdaq: UNCY) announced its financial results for the full year ended December 31, 2025, and provided a business update.Unicycive Therapeutics is a B2i Digital Featured… | David Shapiro
Unicycive Therapeutics (Nasdaq: UNCY) announced its financial res…
1 month ago
linkedin.com
News for UNCY
News for UNCY
Jan 24, 2025
zacks.com
Unicycive Therapeutics (Nasdaq: UNCY) announced that the FDA has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the company’s investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. The FDA deemed the resubmission a Class II complete response, resulting in a six-month review period, and assigned a PDUFA target action date of June 29, 2026. Unicycive Therapeutics is a B2i
0:15
Unicycive Therapeutics (Nasdaq: UNCY) announced that the FDA ha…
3.4K views3 months ago
FacebookB2i Digital
L’intelligence surprenante des pieuvres
0:05
L’intelligence surprenante des pieuvres
8K views1 month ago
YouTubeFaits Réels
Unicycive Therapeutics (Nasdaq: UNCY) recently released an updated company presentation highlighting several financial aspects of the biotechnology company. Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at https://b2idigital.com/unicycive. Highlights from the investor presentation include: • Unaudited cash and cash equivalents of $22.3 million as of June 30, 2025 • Cash runway currently expected into 2H 2026 • Potential future funding of up to $102 mi
0:20
Unicycive Therapeutics (Nasdaq: UNCY) recently released an updat…
1.4K views7 months ago
FacebookB2i Digital
Unicycive Therapeutics (Nasdaq: UNCY) announced Q3 2025 results and remains on track to resubmit its NDA for oxylanthanum carbonate (OLC) by year-end. Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at https://b2idigital.com/unicycive. The company reported solid progress on multiple fronts, including resolution of FDA manufacturing concerns, presentation of compelling pill burden reduction data at ASN Kidney Week 2025, and a strengthened balance sheet w
0:10
Unicycive Therapeutics (Nasdaq: UNCY) announced Q3 2025 result…
155 views5 months ago
FacebookB2i Digital
Oncolytics Biotech announces type C FDA meeting to discuss single-arm registrational pathway for pelareorep in anal cancer
Oncolytics Biotech announces type C FDA meeting to discuss single-a…
1 month ago
marketscreener.com
3:46
ICYMI: The FDA just completed its biggest transformation yet, reachi…
505 viewsDec 11, 2024
FacebookU.S. Food and Drug Administration
5:33
OKYO Pharma clears key FDA meeting for Urcosimod Phase 2b/…
3 months ago
YahooProactive
0:07
ICYMI: Here is a quick snapshot 📸 of key treatments approved by the U.…
30 viewsMar 3, 2025
FacebookOncLive
0:38
3/4 Sleeve Pokadot Blouse
1 month ago
YouTubeLinda's Favorite Finds
2:36
FDA approves diabetes drug to treat obesity
22.3K viewsJun 7, 2021
YouTubeABC News
5:55
MEDICAL DEVICE CLASSIFICATION
11.3K viewsMay 11, 2020
YouTubeDesign Engineer's Cart
27:10
Overview of Post-approval Chemistry, Manufacture, and Cont…
10.2K viewsAug 31, 2020
YouTubeU.S. Food and Drug Administration
41:00
FDA Regulatory Requirements for Clinical Investigators and Case Ex…
4.5K viewsMay 15, 2020
YouTubeU.S. Food and Drug Administration
0:41
3年ぶりの客室乗務員採用へ JAL内定者300人集う(2022年10月3日)
22.6K viewsOct 3, 2022
YouTubeANNnewsCH
13:32
FDA guidance for the content of human factors in medical device 5…
880 viewsDec 16, 2022
YouTubeMedical Device Academy
2:09:08
FDA Clinical Investigator Training Course (CITC) 2022, Day 2 – Part 1
2.3K viewsDec 14, 2022
YouTubeU.S. Food and Drug Administration
0:47
SAMURAI STAND UP! (CoryxKenshin’s Motivational Spe…
1.2K views3 months ago
YouTubeShaderXSlash
1:20
Mr incredible Becoming Uncanny - Phase 3 (Full Music)
115.4K viewsAug 22, 2022
YouTubemr incredible becoming uncanny HD
8:32:40
🟢LiVE Fukuoka (Japan) Airport Plane Spotting✈️福岡空港ライブカメラ …
25.1K viewsJan 18, 2025
YouTubeMED Sky LiVE
0:30
Powerful tool – Dissolution Profile Comparisons (f1 and f2) – tech-pu…
Jan 2, 2021
tech-publish.com
0:42
NUMAN WATER PUMP X1 SERIES
7 views2 months ago
YouTubeNUMAN Life Indonesia
2:25
LILTAE2 X MG SLEEPY TYPE BEAT - "Uncy"
93 views2 weeks ago
YouTubeprod.trapkan
6:14
Pharmaceuticals FDA GMP Overview (21CFR211)
62.6K viewsMar 20, 2013
YouTubeCALISO9000
57:47
FDA 101 for Medical Devices
39.3K viewsSep 20, 2018
YouTubeRegistrar Corp
9:28
Medical Device Regulations / FDA Approval
40.8K viewsJul 16, 2020
YouTubeThe BME Life
46:23
Electronic Common Technical Document (eCTD)
13.9K viewsJul 29, 2021
YouTubeU.S. Food and Drug Administration
1:02:35
21 CFR Part 210, 211 and eCFR
11.2K viewsJun 11, 2020
YouTubeHitendrakumar Shah
48:21
FDA Adverse Event Reporting System (FAERS) Overview - Phar…
9.9K viewsJun 15, 2020
YouTubeU.S. Food and Drug Administration
See more videos
Static thumbnail place holder